Press Releases

Date Title and Summary Additional Formats
Toggle Summary Harvard Bioscience Reports First Quarter 2019 Financial Results
Reports both GAAP and adjusted non-GAAP revenue of $28.2 million, an increase of 5% and 2%, respectively HOLLISTON, Mass. , May 02, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), or the Company, a global developer, manufacturer and marketer of a broad range of solutions to
View HTML
Toggle Summary Harvard Bioscience Schedules First Quarter 2019 Conference Call for May 2 at 4:30 PM ET
HOLLISTON, Mass. , April 23, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2019 after market trading hours on Thursday, May 2, 2019 .
View HTML
Toggle Summary Harvard Bioscience Subsidiary Data Sciences International Wins Award for Best Achievement of Operational Excellence in Pharmaceuticals & Life Sciences
Company Receives Honor at Business Transformation & Operational Excellence Industry Awards 2019 in Orlando, Florida HOLLISTON, Mass. , April 03, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and
View HTML
Toggle Summary Harvard Bioscience To Showcase Products at Experimental Biology 2019
All Three Commercial Units to Be Represented HOLLISTON, Mass. , March 26, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is presenting new laboratory products and applications for
View HTML
Toggle Summary Harvard Bioscience Reports Strong Fourth Quarter and Year-End 2018 Results, and Issues 2019 Financial Guidance
-Reports record Fourth Quarter GAAP and adjusted non-GAAP revenue of $33.9 million, a year-over-year increase of 56% and 24%, respectively- HOLLISTON, Mass. , Feb. 28, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of
View HTML
Toggle Summary Harvard Bioscience Subsidiary Data Sciences International to Participate at SOT 2019 With Presentation and Exhibit
Company To Sponsor Session on Novel Approaches for Respiratory Measurement, Showcase Portfolio of Instrumentation Products and Solutions and Present Data HOLLISTON, Mass. , Feb. 26, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard Bioscience , Inc. (Nasdaq: HBIO),
View HTML
Toggle Summary Harvard Bioscience Schedules Fourth Quarter 2018 Conference Call for February 28 at 4:30 PM ET
HOLLISTON, Mass. , Feb. 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its fourth quarter 2018 after market trading hours on Thursday, February 28,
View HTML
Toggle Summary Harvard Bioscience Presents Data, Symposium Session and New Products at Neuroscience 2018
HOLLISTON, Mass. , Nov. 02, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is presenting its new neuroscience products and applications for preclinical life science research at
View HTML
Toggle Summary Harvard Bioscience Reports Third Quarter 2018 Financial Results
-Reports GAAP and adjusted non-GAAP revenue of $28.6 million and $28.7 million , respectively, an increase of 53% and 15%, respectively- HOLLISTON, Mass. , Oct. 25, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a
View HTML
Toggle Summary Harvard Bioscience Names Kam Unninayar as Chief Financial Officer
Seasoned Financial Executive With More Than a Decade in Global Life Science Instrumentation, Will Begin on November 26 HOLLISTON, Mass. , Oct. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience , Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of
View HTML